News | July 06, 2012

Breast Cancer Risk Can Be Lowered by Avoiding Unnecessary Medical Imaging

UCSF analysis of IOM report on environmental causes of breast cancer suggests way to reduce risk

July 6, 2012 — A report issued by the Institute of Medicine (IOM) last December reviewed all the available scientific data compiled to date about potential environmental risks of breast cancer—factors such as pesticides, beauty products, household chemicals and the plastics used to make water bottles.

Commissioned by the breast cancer foundation Susan G. Komen for the Cure, the IOM report concluded that there was not enough data to confirm or rule out that exposure to most of these factors caused breast cancer. However, the report did identify two factors that definitely increased risk: post-menopausal hormone replacement therapy and radiation exposure from medical imaging.

Now, a special article in the journal Archives of Internal Medicine details the findings of the IOM report as they relate to medical imaging, and what women can do to minimize their risk of breast cancer.

“The single thing that the IOM highlighted that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging,” said Rebecca Smith-Bindman, M.D., professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who wrote the article and contributed to the IOM report.

What a Woman Should Know to Ask Her Doctor
While CT (computed tomography) scans and other forms of medical imaging have revolutionized medicine and can be life-saving, said Smith-Bindman, women need to engage their doctors in the decision-making process and insist on the necessity and safety of all radiological scans they undergo.

"They should understand the risks and benefits and ask their doctor to explain the risks and benefits as well as the radiation burden from the scan,” said Smith-Bindman.

Questions patients should ask their doctors questions include:

  • Is this scan absolutely necessary or can we make decisions about my care without it?
  • Is it necessary to do it now?
  • Are there other alternative tests?
  • How can I be sure the test will be done in the safest way possible?
  • Will having the scan information change the management of my disease in a positive way that cannot happen without the scan?
  • Can I wait until after seeing a specialist before getting the scan?


The article, “Environmental Causes of Breast Cancer and Radiation from Medical Imaging/Findings from the Institute of Medicine Report,” appears in the Archives of Internal Medicine on June 11, 2012.

For more information: www.archinte.jamanetwork.com

Related Content

Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init